Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor–deficient mice by altering lymphocyte and macrophage …
LJ Pinderski, MP Fischbein… - Circulation …, 2002 - Am Heart Assoc
Previous studies demonstrated that interleukin-10 (IL-10) overexpression decreases
formation of early fatty-streak lesions in mice independent of lipoprotein levels. The present …
formation of early fatty-streak lesions in mice independent of lipoprotein levels. The present …
Multidimensional contribution of matrix metalloproteinases to atherosclerotic plaque vulnerability: multiple mechanisms of inhibition to promote stability
JM Ruddy, JS Ikonomidis, JA Jones - Journal of vascular research, 2016 - karger.com
The prevalence of atherosclerotic disease continues to increase, and despite significant
reductions in major cardiovascular events with current medical interventions, an additional …
reductions in major cardiovascular events with current medical interventions, an additional …
Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation
K Nakamura, T Sasaki, XW Cheng, A Iguchi, K Sato… - Atherosclerosis, 2009 - Elsevier
Although it has been demonstrated that statins stabilize atherosclerotic lesions in animal
models of advanced atherosclerosis, there is little evidence to suggest that statins have a …
models of advanced atherosclerosis, there is little evidence to suggest that statins have a …
[HTML][HTML] An interleukin-6 receptor antibody suppresses atherosclerosis in atherogenic mice
K Akita, K Isoda, Y Sato-Okabayashi… - Frontiers in …, 2017 - frontiersin.org
IκBNS is a nuclear IκB protein which negatively regulates nuclear factor-κB activity. We
demonstrated that IκBNS deficiency accelerates atherosclerosis in LDL receptor-deficient …
demonstrated that IκBNS deficiency accelerates atherosclerosis in LDL receptor-deficient …
Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening
VA Korshunov, BC Berk - Arteriosclerosis, thrombosis, and …, 2003 - Am Heart Assoc
Objective—Vascular remodeling of the carotid artery with intima-media thickness (IMT) is an
important predictive factor for human cardiovascular disease. We characterized a mouse …
important predictive factor for human cardiovascular disease. We characterized a mouse …
Genetic and pharmacological targeting of phosphoinositide 3-kinase-γ reduces atherosclerosis and favors plaque stability by modulating inflammatory processes
A Fougerat, S Gayral, P Gourdy, A Schambourg… - Circulation, 2008 - Am Heart Assoc
Background—The role of inflammation at all stages of the atherosclerotic process has
become an active area of investigation, and there is a notable quest for novel and innovative …
become an active area of investigation, and there is a notable quest for novel and innovative …
Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and …
JX Rong, J Li, ED Reis, RP Choudhury, HM Dansky… - Circulation, 2001 - Am Heart Assoc
Background HDL cholesterol levels are inversely correlated with coronary heart disease risk
in humans, and in animal studies, HDL elevation decreases formation and progression of …
in humans, and in animal studies, HDL elevation decreases formation and progression of …
A simple method of plaque rupture induction in apolipoprotein E–deficient mice
T Sasaki, M Kuzuya, K Nakamura… - … , and vascular biology, 2006 - Am Heart Assoc
Objective—The development of a murine model of atherosclerotic plaque rupture. Methods
and Results—The left common carotid arteries of male apolipoprotein E (apoE)–deficient …
and Results—The left common carotid arteries of male apolipoprotein E (apoE)–deficient …
Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E–deficient mice
Epidemiological studies suggest that elevated plasma levels of plasminogen activator
inhibitor-1 (PAI-1) predispose an individual to ischemic heart disease or promote plaque …
inhibitor-1 (PAI-1) predispose an individual to ischemic heart disease or promote plaque …
Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation
WF Johnston, M Salmon, G Su, G Lu… - … , and vascular biology, 2013 - Am Heart Assoc
Objective—Abdominal aortic aneurysms (AAAs) are common, but their exact pathogenesis
remains unknown and no specific medical therapies are available. We sought to evaluate …
remains unknown and no specific medical therapies are available. We sought to evaluate …